Eli Lilly and Company has announced its acquisition of Kelonia Therapeutics for up to $7 billion, marking a strategic move to bolster its oncology portfolio. The agreement includes an initial payment of $3.25 billion, with additional milestone payments linked to clinical and regulatory achievements. This acquisition is expected to enhance Lilly's capabilities in cancer treatments, aligning with its goal to diversify beyond its successful obesity and diabetes offerings in the $240 billion oncology market.
“I'm glad that we went relatively small. We didn't get the breakdown that we were looking for in USO as it's climbing higher.”
“Thoughts on Intel going higher or lower from here? Seems like support at 48 halves. Yeah, I I was watching Intel this morning. I had a support line down here at 45s to be honest.”
“Not only that, look at this end of the day. Strong aggressive sellers pushing in into this area. Once again in and around this area 4770s sellers step in and we get a multi-day selloff there on Intel.”
“it’s a big time breakout in Eli Lilly.”
“Google relatively strong Apple relatively weak uh is a good example. So, if Apple starts to break down and Google starts to curl over, then that adds confluence for a potential pullback as well for me at the very least.”
“Google relatively strong Apple relatively weak uh is a good example. So, if Apple starts to break down and Google starts to curl over, then that adds confluence for a potential pullback as well for me at the very least.”
“FDA approves El Eli Liy's GLP1 weight loss pill... starts shipping Monday via Lily Direct. $25 a month with insurance.”
“$25 a month with insurance. 149 to 349 out of pocket depending on the dose.”
“starts shipping Monday via Lily Direct.”
“Guess what? They're going to be using AI. They're using technology to create their blockbuster treatments and solutions, and that's how come, you know, they're going to take over healthcare and they're going to win. But that's they are an AI company, technology company.”
“Could weight loss drugs be the biggest pharma opportunity of our lifetime? Pills, lower costs, and mass production could soon unlock a much bigger market for stocks like $LLY and $NVO.”
“BREAKING: Eli Lilly to buy Kelonia Therapeutics in up to $7 billion cancer immunotherapy drug deal, @angelicapeebles reports $LLY”
